An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure

Kazuki Shimoishi, Makoto Anraku, Kenichiro Kitamura, Yuka Tasaki, Kazuaki Taguchi, Mitsuru Hashimoto, Eiko Fukunaga, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Purpose. The effect of AST-120, an oral adsorbent, on oxidative stress in the systemic circulation in chronic renal failure (CRF) was examined and the potential role of indoxyl sulfate (IS), an uremic toxin adsorbed by AST-120, in inducing the formation of reactive oxygen species (ROS) in the vascular system was studied, in vitro and in vivo. Materials and methods. The level of oxidized albumin, a marker for oxidative stress in the systemic circulation was determined by HPLC, as previously reported. The mRNA levels of TGF-β1 and Oat1 were measured by quantitative RT-PCR. The IS induced ROS generation in cultured human umbilical vein endothelial cells (HUVECs) was estimated using a fluorescence microplate reader. Results. An increase in the ratio of oxidized to unoxidized albumin was determined using 5/6 nephrectomized rats (CRF rats) compared to a control group. The ratio was significantly reduced in the group that received AST-120 of 4 weeks, suggesting that AST-120 inhibits oxidative stress in CRF. An anti-oxidative effect of AST-120 was also observed in CRF rats with a similar renal function. The ratio of oxidized albumin was correlated with serum IS levels in vivo. The same relationship was also observed in CRF rats with the continued administration of IS. In addition, IS dramatically increased the generation of ROS in both a dose- and time- dependent manner in HUVEC, suggesting that accumulated IS may play an important role in enhancing intravascular oxidative stress. Conclusion. We propose that AST-120 reduces IS concentrations in the blood that induces ROS production in endothelial cells, thereby inhibiting the subsequent occurrence of oxidative stress in the systemic circulation in renal failure.

Original languageEnglish
Pages (from-to)1283-1289
Number of pages7
JournalPharmaceutical Research
Volume24
Issue number7
DOIs
Publication statusPublished - 2007 Jul 1
Externally publishedYes

Fingerprint

Indican
Oxidative stress
Adsorbents
Renal Insufficiency
Oxidative Stress
Chronic Kidney Failure
Rats
Reactive Oxygen Species
Endothelial cells
Albumins
Human Umbilical Vein Endothelial Cells
AST 120
Blood Vessels
Blood
Endothelial Cells
Fluorescence
High Pressure Liquid Chromatography
Kidney
Polymerase Chain Reaction
Control Groups

Keywords

  • Albumin oxidation
  • AST-120
  • Chronic renal failure
  • Indoxyl sulfate

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. / Shimoishi, Kazuki; Anraku, Makoto; Kitamura, Kenichiro; Tasaki, Yuka; Taguchi, Kazuaki; Hashimoto, Mitsuru; Fukunaga, Eiko; Maruyama, Toru; Otagiri, Masaki.

In: Pharmaceutical Research, Vol. 24, No. 7, 01.07.2007, p. 1283-1289.

Research output: Contribution to journalArticle

Shimoishi, Kazuki ; Anraku, Makoto ; Kitamura, Kenichiro ; Tasaki, Yuka ; Taguchi, Kazuaki ; Hashimoto, Mitsuru ; Fukunaga, Eiko ; Maruyama, Toru ; Otagiri, Masaki. / An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. In: Pharmaceutical Research. 2007 ; Vol. 24, No. 7. pp. 1283-1289.
@article{1f9bbb0e9ec0466c9f92376ebf043e24,
title = "An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure",
abstract = "Purpose. The effect of AST-120, an oral adsorbent, on oxidative stress in the systemic circulation in chronic renal failure (CRF) was examined and the potential role of indoxyl sulfate (IS), an uremic toxin adsorbed by AST-120, in inducing the formation of reactive oxygen species (ROS) in the vascular system was studied, in vitro and in vivo. Materials and methods. The level of oxidized albumin, a marker for oxidative stress in the systemic circulation was determined by HPLC, as previously reported. The mRNA levels of TGF-β1 and Oat1 were measured by quantitative RT-PCR. The IS induced ROS generation in cultured human umbilical vein endothelial cells (HUVECs) was estimated using a fluorescence microplate reader. Results. An increase in the ratio of oxidized to unoxidized albumin was determined using 5/6 nephrectomized rats (CRF rats) compared to a control group. The ratio was significantly reduced in the group that received AST-120 of 4 weeks, suggesting that AST-120 inhibits oxidative stress in CRF. An anti-oxidative effect of AST-120 was also observed in CRF rats with a similar renal function. The ratio of oxidized albumin was correlated with serum IS levels in vivo. The same relationship was also observed in CRF rats with the continued administration of IS. In addition, IS dramatically increased the generation of ROS in both a dose- and time- dependent manner in HUVEC, suggesting that accumulated IS may play an important role in enhancing intravascular oxidative stress. Conclusion. We propose that AST-120 reduces IS concentrations in the blood that induces ROS production in endothelial cells, thereby inhibiting the subsequent occurrence of oxidative stress in the systemic circulation in renal failure.",
keywords = "Albumin oxidation, AST-120, Chronic renal failure, Indoxyl sulfate",
author = "Kazuki Shimoishi and Makoto Anraku and Kenichiro Kitamura and Yuka Tasaki and Kazuaki Taguchi and Mitsuru Hashimoto and Eiko Fukunaga and Toru Maruyama and Masaki Otagiri",
year = "2007",
month = "7",
day = "1",
doi = "10.1007/s11095-007-9248-x",
language = "English",
volume = "24",
pages = "1283--1289",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure

AU - Shimoishi, Kazuki

AU - Anraku, Makoto

AU - Kitamura, Kenichiro

AU - Tasaki, Yuka

AU - Taguchi, Kazuaki

AU - Hashimoto, Mitsuru

AU - Fukunaga, Eiko

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Purpose. The effect of AST-120, an oral adsorbent, on oxidative stress in the systemic circulation in chronic renal failure (CRF) was examined and the potential role of indoxyl sulfate (IS), an uremic toxin adsorbed by AST-120, in inducing the formation of reactive oxygen species (ROS) in the vascular system was studied, in vitro and in vivo. Materials and methods. The level of oxidized albumin, a marker for oxidative stress in the systemic circulation was determined by HPLC, as previously reported. The mRNA levels of TGF-β1 and Oat1 were measured by quantitative RT-PCR. The IS induced ROS generation in cultured human umbilical vein endothelial cells (HUVECs) was estimated using a fluorescence microplate reader. Results. An increase in the ratio of oxidized to unoxidized albumin was determined using 5/6 nephrectomized rats (CRF rats) compared to a control group. The ratio was significantly reduced in the group that received AST-120 of 4 weeks, suggesting that AST-120 inhibits oxidative stress in CRF. An anti-oxidative effect of AST-120 was also observed in CRF rats with a similar renal function. The ratio of oxidized albumin was correlated with serum IS levels in vivo. The same relationship was also observed in CRF rats with the continued administration of IS. In addition, IS dramatically increased the generation of ROS in both a dose- and time- dependent manner in HUVEC, suggesting that accumulated IS may play an important role in enhancing intravascular oxidative stress. Conclusion. We propose that AST-120 reduces IS concentrations in the blood that induces ROS production in endothelial cells, thereby inhibiting the subsequent occurrence of oxidative stress in the systemic circulation in renal failure.

AB - Purpose. The effect of AST-120, an oral adsorbent, on oxidative stress in the systemic circulation in chronic renal failure (CRF) was examined and the potential role of indoxyl sulfate (IS), an uremic toxin adsorbed by AST-120, in inducing the formation of reactive oxygen species (ROS) in the vascular system was studied, in vitro and in vivo. Materials and methods. The level of oxidized albumin, a marker for oxidative stress in the systemic circulation was determined by HPLC, as previously reported. The mRNA levels of TGF-β1 and Oat1 were measured by quantitative RT-PCR. The IS induced ROS generation in cultured human umbilical vein endothelial cells (HUVECs) was estimated using a fluorescence microplate reader. Results. An increase in the ratio of oxidized to unoxidized albumin was determined using 5/6 nephrectomized rats (CRF rats) compared to a control group. The ratio was significantly reduced in the group that received AST-120 of 4 weeks, suggesting that AST-120 inhibits oxidative stress in CRF. An anti-oxidative effect of AST-120 was also observed in CRF rats with a similar renal function. The ratio of oxidized albumin was correlated with serum IS levels in vivo. The same relationship was also observed in CRF rats with the continued administration of IS. In addition, IS dramatically increased the generation of ROS in both a dose- and time- dependent manner in HUVEC, suggesting that accumulated IS may play an important role in enhancing intravascular oxidative stress. Conclusion. We propose that AST-120 reduces IS concentrations in the blood that induces ROS production in endothelial cells, thereby inhibiting the subsequent occurrence of oxidative stress in the systemic circulation in renal failure.

KW - Albumin oxidation

KW - AST-120

KW - Chronic renal failure

KW - Indoxyl sulfate

UR - http://www.scopus.com/inward/record.url?scp=34249915064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249915064&partnerID=8YFLogxK

U2 - 10.1007/s11095-007-9248-x

DO - 10.1007/s11095-007-9248-x

M3 - Article

VL - 24

SP - 1283

EP - 1289

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 7

ER -